Viewing StudyNCT02169609



Ignite Creation Date: 2024-05-06 @ 2:57 AM
Last Modification Date: 2024-10-26 @ 11:26 AM
Study NCT ID: NCT02169609
Status: COMPLETED
Last Update Posted: 2024-04-22
First Post: 2014-06-12

Brief Title: Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
Sponsor: Fundació Sant Joan de Déu
Organization: Fundació Sant Joan de Déu

Conditions & Keywords Data

Conditions:
Name
Effects of Immunotherapy
Neuroblastoma
Neoplasm Residual
Keywords:
Name View
Dinutuximab View
Neuroblastoma View
Immunotherapy View